Bank of New York Mellon’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.81M Buy
382,920
+4,217
+1% +$37.7K ﹤0.01% 2466
2025
Q4
$3.2M Buy
378,703
+7,125
+2% +$50.8K ﹤0.01% 2581
2025
Q3
$1.94M Buy
371,578
+13,207
+4% +$50.4K ﹤0.01% 2821
2025
Q2
$1.24M Buy
358,371
+28,466
+9% +$84.7K ﹤0.01% 3005
2025
Q1
$864K Buy
329,905
+1,008
+0.3% +$3.95K ﹤0.01% 3148
2024
Q4
$1.36M Buy
328,897
+50,190
+18% +$273K ﹤0.01% 2958
2024
Q3
$1.97M Sell
278,707
-75,960
-21% -$567K ﹤0.01% 2749
2024
Q2
$2.31M Buy
354,667
+48,219
+16% +$329K ﹤0.01% 2719
2024
Q1
$2.54M Sell
306,448
-15,613
-5% -$152K ﹤0.01% 2644
2023
Q4
$3.55M Sell
322,061
-459
-0.1% -$3.87K ﹤0.01% 2539
2023
Q3
$2.71M Buy
322,520
+759
+0.2% +$8.16K ﹤0.01% 2637
2023
Q2
$4.04M Sell
321,761
-54,240
-14% -$675K ﹤0.01% 2439
2023
Q1
$6.19M Sell
376,001
-12,484
-3% -$224K ﹤0.01% 2184
2022
Q4
$5.8M Buy
388,485
+46,233
+14% +$885K ﹤0.01% 2254
2022
Q3
$7.66M Buy
342,252
+44,636
+15% +$979K ﹤0.01% 2061
2022
Q2
$4.99M Buy
297,616
+10,730
+4% +$230K ﹤0.01% 2302
2022
Q1
$8.59M Buy
286,886
+5,958
+2% +$145K ﹤0.01% 2152
2021
Q4
$8.63M Buy
280,928
+46,046
+20% +$1.46M ﹤0.01% 2182
2021
Q3
$7.41M Buy
234,882
+67,509
+40% +$2.27M ﹤0.01% 2287
2021
Q2
$6.12M Buy
167,373
+28,508
+21% +$939K ﹤0.01% 2391
2021
Q1
$4.8M Buy
138,865
+23,011
+20% +$999K ﹤0.01% 2459
2020
Q4
$4.81M Buy
115,854
+26,801
+30% +$1.21M ﹤0.01% 2377
2020
Q3
$3.79M Buy
+89,053
New +$3.4M ﹤0.01% 2361

Other funds holding RLAY